Molecular imaging is at the forefront of personalised medicine with several technological developments introducing a paradigm shift in the diagnosis, staging and treatment follow-up of patients. Among them, the quest for a higher sensitivity through improved Time-of-Flight PET (TOF-PET) performance and enlarged field of view with Total Body PET (TB-PET) approaches nicely complements a vigorous multimodality effort to combine the merits of PET/SPECT with MRI in single integrated systems.

As the ultimate goal is the same, namely allowing earlier diagnosis of diseases and improving their